hepatocellular carcinoma

Open Access
Correlation Between Low Cytoplasmic Expression of XBP1 and the Likelihood of Surviving Hepatocellular Carcinoma
HUI-TING HSU, YUEH-MIN LIN, MING-TAI HSING, KUN-TU YEH, JENG-WEI LU and SHUN-FA YANG

In Vivo May 2024, 38 (3) 1316-1324; DOI: https://doi.org/10.21873/invivo.13571
Open Access
Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model
JR-DI YANG, YU-CHANG LIU, HSIAO-CHIA WANG, FEI-TING HSU, TSAI LAN LIAO, MENG-CHU HUANG and JIANN-HWA CHEN

In Vivo May 2024, 38 (3) 1079-1093; DOI: https://doi.org/10.21873/invivo.13542
Open Access
Determination of the Possible Target Genes of Hepatoma-derived Growth Factor in Hepatoma Cells
HIRAYUKI ENOMOTO, TAKASHI NISHIMURA, SHINYA FUKUNUSHI, HIDEYUKI SHIOMI and HIROKO IIJIMA

In Vivo September 2023, 37 (5) 1975-1979; DOI: https://doi.org/10.21873/invivo.13294
Open Access
Durable Stable Disease by Atezolizumab/Bevacizumab Can Provide Long-term Survival of Patients With Hepatocellular Carcinoma Lung Metastases
TOSHIHIKO MOTOHARA, KENSUKE YAMAMURA, HIDEAKI MIYAMOTO, SHIGENORI UENO, HIROSHI TAKENO, YASUNORI NAGAYAMA, ERI ODA, RYUICHI KARASHIMA, NOBUYUKI OZAKI, TATSUNORI MIYATA, KOSUKE MIMA, HIROHISA OKABE, TAKATOSHI ISIKO and TORU BEPPU

In Vivo September 2023, 37 (5) 2268-2275; DOI: https://doi.org/10.21873/invivo.13329
Open Access
The Combination Sorafenib-raloxifene-loratadine as a Novel Potential Therapeutic Approach Against Human Liver Cancer
FERNANDA VILLARRUEL-MELQUIADES, ELIZABETH HERNANDEZ-GALLEGOS, CARMEN SOLANO-AGAMA, MARIA EUGENIA MENDOZA-GARRIDO and JAVIER CAMACHO

In Vivo May 2023, 37 (3) 1156-1163; DOI: https://doi.org/10.21873/invivo.13190
Open Access
Hyperglycemia Alters O-GlcNAcylation Patterns of Hepatocytes in Mice Treated With Hepatoxic Carcinogen
SURANG CHOMPHOO, WARITTA KUNPROM, KANYARAT THITHUAN, SUPANNIKA SORIN, KULLANAT KHAWKHIAW, ANYANEE KAMKAEW, CHATCHAI PHOOMAK, CHING-FENG CHIU and CHARUPONG SAENGBOONMEE

In Vivo March 2023, 37 (2) 685-695; DOI: https://doi.org/10.21873/invivo.13129
Open Access
Association of PNPLA3 SNP With the Development of HBV-related Hepatocellular Carcinoma
HIRAYUKI ENOMOTO, NOBUHIRO AIZAWA, NAOTO IKEDA, TOMOYUKI TAKASHIMA, YUKIHISA YURI, MAMIKO OKAMOTO, RYOTA YOSHIOKA, SHOKI KAWATA, KOHEI YOSHIHARA, SHOGO OTA, RYOTA NAKANO, HIDEYUKI SHIOMI, TAKASHI NISHIMURA and HIROKO IIJIMA

In Vivo March 2023, 37 (2) 763-770; DOI: https://doi.org/10.21873/invivo.13139
Open Access
An Investigation of Popping During Radiofrequency Ablation After Lenvatinib Administration for Hepatocellular Carcinoma
TORU ISHIKAWA, IORI HASEGAWA, HIROSHI HIROSAWA, TSUBASA HONMOU, NOBUYUKI SAKAI, TAKANORI IGARASHI, SHUN YAMAZAKI, TAKAMASA KOBAYASHI, TOSHIFUMI SATO, AKITO IWANAGA, TOMOE SANO, JUNJI YOKOYAMA and TERASU HONMA

In Vivo March 2023, 37 (2) 836-840; DOI: https://doi.org/10.21873/invivo.13150
Open Access
Comparison of Biomarkers Between Hepatic Tumors in Rat Models and a Dog
SOOMIN KIM, YEJI KIM, SE EUN KIM and HA-JUNG KIM

In Vivo January 2023, 37 (1) 252-261; DOI: https://doi.org/10.21873/invivo.13075
Open Access
Bevacizumab and Atezolizumab for Unresectable Hepatocellular Carcinoma: Real-world Data in Taiwan-Tainan Medical Oncology Group H01 Trial
YANG-CHENG LEE, WEN-TSUNG HUANG, MING-YANG LEE, CHAO-JUNG TSAO and YIN-HSUN FENG

In Vivo January 2023, 37 (1) 454-460; DOI: https://doi.org/10.21873/invivo.13099

Main menu

User menu

Search

hepatocellular carcinoma

Pages